PL2342570T3 - Sekretogranina ii jako marker choroby serca - Google Patents
Sekretogranina ii jako marker choroby sercaInfo
- Publication number
- PL2342570T3 PL2342570T3 PL09748433T PL09748433T PL2342570T3 PL 2342570 T3 PL2342570 T3 PL 2342570T3 PL 09748433 T PL09748433 T PL 09748433T PL 09748433 T PL09748433 T PL 09748433T PL 2342570 T3 PL2342570 T3 PL 2342570T3
- Authority
- PL
- Poland
- Prior art keywords
- secretogranin
- marker
- heart disease
- heart
- disease
- Prior art date
Links
- 102000000705 Secretogranin II Human genes 0.000 title 1
- 108010002533 Secretogranin II Proteins 0.000 title 1
- 208000019622 heart disease Diseases 0.000 title 1
- 239000003550 marker Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/326—Arrhythmias, e.g. ventricular fibrillation, tachycardia, atrioventricular block, torsade de pointes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0818650.4A GB0818650D0 (en) | 2008-10-10 | 2008-10-10 | Methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2342570T3 true PL2342570T3 (pl) | 2017-01-31 |
Family
ID=40083871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09748433T PL2342570T3 (pl) | 2008-10-10 | 2009-10-12 | Sekretogranina ii jako marker choroby serca |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8497074B2 (pl) |
| EP (1) | EP2342570B1 (pl) |
| ES (1) | ES2599955T3 (pl) |
| GB (1) | GB0818650D0 (pl) |
| PL (1) | PL2342570T3 (pl) |
| WO (1) | WO2010041046A2 (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201704689XA (en) | 2008-01-18 | 2017-07-28 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
| GB0919901D0 (en) * | 2009-11-13 | 2009-12-30 | Uni I Oslo | Method |
| MX2013000917A (es) | 2010-07-23 | 2013-07-05 | Harvard College | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. |
| CA2806301A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting cardiovascular diseases or conditions |
| SG10201505723UA (en) | 2010-07-23 | 2015-09-29 | Harvard College | Methods for detecting signatures of disease or conditions in bodily fluids |
| AU2011280997A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
| CA2806304A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
| PL2734222T3 (pl) | 2011-07-18 | 2017-03-31 | Critical Care Diagnostics, Inc. | Sposoby leczenia chorób układu krążenia i prognozowania skuteczności terapii ruchowej |
| AU2013262515B2 (en) * | 2012-05-18 | 2018-03-15 | Cardiac Pacemakers, Inc. | Methods for treating or predicting risk of a ventricular tachyarrhythmia event |
| EA201590024A1 (ru) | 2012-06-15 | 2015-05-29 | Гарри Стилли | Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток |
| CN104603289A (zh) | 2012-06-15 | 2015-05-06 | 哈里·斯泰利 | 检测疾病或病状的方法 |
| WO2014164362A1 (en) | 2013-03-09 | 2014-10-09 | Harry Stylli | Methods of detecting prostate cancer |
| NZ771629A (en) | 2013-03-09 | 2022-12-23 | Harry Stylli | Methods of detecting cancer |
| EP4428251A3 (en) | 2014-09-11 | 2024-12-18 | Immunis.AI, Inc. | Methods of detecting prostate cancer |
| NO348199B1 (en) * | 2023-07-13 | 2024-09-30 | CardiNor AS | Immunoassay and method for determining secretoneurin peptide concentration |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6238877B1 (en) | 1997-11-05 | 2001-05-29 | Arup Institute | Method for prediction prostate cancer patients' resistance to hormonal treatment by measuring serum concentrations of chromogranin A |
| FR2778744B1 (fr) | 1998-05-14 | 2000-06-23 | Cis Bio Int | Dosage immunologique de la chromogranine a humaine (cga) anticorps, reactifs et trousses utilisables pour ce dosage |
| ITMI20011833A1 (it) | 2001-08-31 | 2003-03-03 | San Raffaele Centro Fond | Agenti che regolano la permeabilita' vascolare |
| US7794948B2 (en) | 2003-11-07 | 2010-09-14 | Vermilllion, Inc. | Biomarkers for alzheimer's disease |
-
2008
- 2008-10-10 GB GBGB0818650.4A patent/GB0818650D0/en not_active Ceased
-
2009
- 2009-10-12 EP EP09748433.1A patent/EP2342570B1/en active Active
- 2009-10-12 WO PCT/GB2009/002454 patent/WO2010041046A2/en not_active Ceased
- 2009-10-12 US US13/122,131 patent/US8497074B2/en active Active
- 2009-10-12 PL PL09748433T patent/PL2342570T3/pl unknown
- 2009-10-12 ES ES09748433.1T patent/ES2599955T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010041046A2 (en) | 2010-04-15 |
| ES2599955T3 (es) | 2017-02-06 |
| EP2342570A2 (en) | 2011-07-13 |
| GB0818650D0 (en) | 2008-11-19 |
| US8497074B2 (en) | 2013-07-30 |
| WO2010041046A3 (en) | 2010-06-24 |
| US20110223106A1 (en) | 2011-09-15 |
| EP2342570B1 (en) | 2016-08-03 |
| WO2010041046A8 (en) | 2011-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL215270A0 (en) | Synthesis of 2'-o-fucosyllactose | |
| GB2473392B (en) | Methods of diagnosis | |
| BRPI1012116A2 (pt) | composição farmacêutica para o tratamento de doenças cardíacas | |
| EP2398483A4 (en) | Oxyntomodulin Analogs | |
| IL209855A0 (en) | Supression of neuroedocrine diseases | |
| EP2285299A4 (en) | UNIVERSAL ANCHORING FOR FIXING OBJECTS TO BONE TISSUE | |
| PL3064206T3 (pl) | Leczenie choroby Huntingtona z zastosowaniem lakwinimodu | |
| GB0907874D0 (en) | Skin marker | |
| EP2348988A4 (en) | DETERMINATION OF PHYSIOLOGICAL PROPERTIES OF ANIMALS | |
| GB0908193D0 (en) | Treatment of disease state | |
| EP2423683A4 (en) | MARKER FOR DENTISTRY DISEASES | |
| SI2326632T1 (sl) | Nov kokristal holin epalrestata | |
| IT1395539B1 (it) | Piede d'appoggio | |
| IL206577A0 (en) | Formulations of flibanserin | |
| ZA201003867B (en) | Treatment of heart disease using b-blockers | |
| HUP1100131A2 (en) | Diagnosis of systemic diseases | |
| GB0814296D0 (en) | Improvements to coffins | |
| GB0903858D0 (en) | Diagnosis of disease | |
| PT2526422T (pt) | Método de diagnóstico da doença de sjögren | |
| EP2331490A4 (en) | PREPARATION OF DIBUTOXYMETHANE | |
| IT1391776B1 (it) | Procedimento per la preparazione di dexlansoprazolo | |
| ITMI20080011A1 (it) | Procedimento per la preparazione di diacereina | |
| GB201019043D0 (en) | Use of 2',5'-oligoadenylate derivative compounds | |
| GB0819543D0 (en) | Treatment of proteostatic disease | |
| GB0817859D0 (en) | Treatment of proteostatic disease |